AAAAAA

   
Results: 1-11 |
Results: 11
EVALUATION OF BIOMARKERS OF SURVIVAL RESPONSE IN HORMONE-REFRACTORY PROSTATE-CANCER PATIENTS TREATED WITH SURAMIN
Authors: SRIDHARA R EISENBERGER MA SINIBALDI VJ REYNO LM EGORIN MJ
Citation: R. Sridhara et al., EVALUATION OF BIOMARKERS OF SURVIVAL RESPONSE IN HORMONE-REFRACTORY PROSTATE-CANCER PATIENTS TREATED WITH SURAMIN, Cancer epidemiology, biomarkers & prevention, 7(7), 1998, pp. 631-634
PHASE-I AND CLINICAL-EVALUATION OF A PHARMACOLOGICALLY GUIDED REGIMENOF SURAMIN IN PATIENTS WITH HORMONE-REFRACTORY PROSTATE-CANCER
Authors: EISENBERGER MA SINIBALDI VJ REYNO LM SRIDHARA R JODRELL DI ZUHOWSKI EG TKACZUK KH LOWITT MH HEMADY RK JACOBS SC VANECHO D EGORIN MJ
Citation: Ma. Eisenberger et al., PHASE-I AND CLINICAL-EVALUATION OF A PHARMACOLOGICALLY GUIDED REGIMENOF SURAMIN IN PATIENTS WITH HORMONE-REFRACTORY PROSTATE-CANCER, Journal of clinical oncology, 13(9), 1995, pp. 2174-2186
DEVELOPMENT AND VALIDATION OF A PHARMACOKINETICALLY BASED FIXED DOSING SCHEME FOR SURAMIN
Authors: REYNO LM EGORIN MJ EISENBERGER MA SINIBALDI VJ ZUHOWSKI EG SRIDHARA R
Citation: Lm. Reyno et al., DEVELOPMENT AND VALIDATION OF A PHARMACOKINETICALLY BASED FIXED DOSING SCHEME FOR SURAMIN, Journal of clinical oncology, 13(9), 1995, pp. 2187-2195
EVALUATION OF PROSTATE-SPECIFIC ANTIGEN AS A SURROGATE MARKER FOR RESPONSE OF HORMONE-REFRACTORY PROSTATE-CANCER TO SURAMIN THERAPY
Authors: SRIDHARA R EISENBERGER MA SINIBALDI VJ REYNO LM EGORIN MJ
Citation: R. Sridhara et al., EVALUATION OF PROSTATE-SPECIFIC ANTIGEN AS A SURROGATE MARKER FOR RESPONSE OF HORMONE-REFRACTORY PROSTATE-CANCER TO SURAMIN THERAPY, Journal of clinical oncology, 13(12), 1995, pp. 2944-2953
EFFECTS OF STORAGE ON THE BINDING OF CARBOPLATIN TO PLASMA-PROTEINS
Authors: ERKMEN K EGORIN MJ REYNO LM MORGAN R DOROSHOW JH
Citation: K. Erkmen et al., EFFECTS OF STORAGE ON THE BINDING OF CARBOPLATIN TO PLASMA-PROTEINS, Cancer chemotherapy and pharmacology, 35(3), 1995, pp. 254-256
SURAMIN, AN ACTIVE-DRUG FOR PROSTATE-CANCER - INTERIM OBSERVATIONS INA PHASE-I TRIAL (VOL 85, PG 611, 1993)
Authors: EISENBERGER MA REYNO LM JODRELL DI
Citation: Ma. Eisenberger et al., SURAMIN, AN ACTIVE-DRUG FOR PROSTATE-CANCER - INTERIM OBSERVATIONS INA PHASE-I TRIAL (VOL 85, PG 611, 1993), Journal of the National Cancer Institute, 86(8), 1994, pp. 639-640
SURAMIN - DEVELOPMENT OF A POPULATION PHARMACOKINETIC MODEL AND ITS USE WITH INTERMITTENT SHORT INFUSIONS TO CONTROL PLASMA DRUG CONCENTRATION IN PATIENTS WITH PROSTATE-CANCER
Authors: JODRELL DI REYNO LM SRIDHARA R EISENBERGER MA TKACZUK KH ZUHOWSKI EG SINIBALDI VJ NOVAK MJ EGORIN MJ
Citation: Di. Jodrell et al., SURAMIN - DEVELOPMENT OF A POPULATION PHARMACOKINETIC MODEL AND ITS USE WITH INTERMITTENT SHORT INFUSIONS TO CONTROL PLASMA DRUG CONCENTRATION IN PATIENTS WITH PROSTATE-CANCER, Journal of clinical oncology, 12(1), 1994, pp. 166-175
SURAMIN
Authors: EISENBERGER MA REYNO LM
Citation: Ma. Eisenberger et Lm. Reyno, SURAMIN, Cancer treatment reviews, 20(3), 1994, pp. 259-273
MODELING TOXICITY AND RESPONSE IN CARBOPLATIN-BASED COMBINATION CHEMOTHERAPY
Authors: EGORIN MJ REYNO LM CANETTA RM JODRELL DI SWENERTON KD PATER JL BURROUGHS JN NOVAK MJ SRIDHARA R
Citation: Mj. Egorin et al., MODELING TOXICITY AND RESPONSE IN CARBOPLATIN-BASED COMBINATION CHEMOTHERAPY, Seminars in oncology, 21(5), 1994, pp. 7-19
POTENTIATION BY INTERLEUKIN-1-ALPHA OF CISPLATIN AND CARBOPLATIN ANTITUMOR-ACTIVITY - SCHEDULE-DEPENDENT AND PHARMACOKINETIC EFFECTS IN THERIF-1 TUMOR-MODEL
Authors: CHANG MJ YU WD REYNO LM MODZELEWSKI RA EGORIN MJ ERKMEN K VLOCK DR FURMANSKI P JOHNSON CS
Citation: Mj. Chang et al., POTENTIATION BY INTERLEUKIN-1-ALPHA OF CISPLATIN AND CARBOPLATIN ANTITUMOR-ACTIVITY - SCHEDULE-DEPENDENT AND PHARMACOKINETIC EFFECTS IN THERIF-1 TUMOR-MODEL, Cancer research, 54(20), 1994, pp. 5380-5386
IMPACT OF CYCLOPHOSPHAMIDE ON RELATIONSHIPS BETWEEN CARBOPLATIN EXPOSURE AND RESPONSE OR TOXICITY WHEN USED IN THE TREATMENT OF ADVANCED OVARIAN-CANCER
Authors: REYNO LM EGORIN MJ CANETTA RM JODRELL DI SWENERTON KD PATER JL BURROUGHS JN NOVAK MJ SRIDHARA R
Citation: Lm. Reyno et al., IMPACT OF CYCLOPHOSPHAMIDE ON RELATIONSHIPS BETWEEN CARBOPLATIN EXPOSURE AND RESPONSE OR TOXICITY WHEN USED IN THE TREATMENT OF ADVANCED OVARIAN-CANCER, Journal of clinical oncology, 11(6), 1993, pp. 1156-1164
Risultati: 1-11 |